Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» sickle cell disease
sickle cell disease
Beam Therapeutics to cut 20% of workforce as part of restructuring plan
Reuters
Thu, 10/19/23 - 10:04 am
Beam Therapeutics
layoffs
sickle cell disease
AATD
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
Fulcrum's sickle cell disease program is back in business after FDA lifts 6-month hold
Fierce Biotech
Tue, 08/22/23 - 10:01 am
Fulcrum Therapeutics
sickle cell disease
clinical trials
FDX-6058
Bluebird’s Lovo-Cel Gene Therapy for SCD Will Not Face FDA Adcomm
BioSpace
Wed, 08/16/23 - 11:09 pm
Bluebird Bio
sickle cell disease
lovo-cel
FDA
Bluebird touts Zynteglo, Skysona launch progress as FDA decision on sickle cell therapy nears
Fierce Pharma
Tue, 08/8/23 - 11:33 am
Bluebird Bio
Zynteglo
Skysona
FDA
sickle cell disease
gene therapy
Novartis sickle cell drug’s approval formally revoked by EU regulators
BioPharma Dive
Sun, 08/6/23 - 09:27 pm
Novartis
Adakveo
sickle cell disease
Europe
EMA
Pfizer takes scalpel to early-phase pipeline, slicing off RSV, eczema, sickle cell and cancer programs
Fierce Biotech
Tue, 08/1/23 - 10:09 am
Pfizer
RSV
sickle cell disease
pneumococcal disease
cancer
Pfizer to end license deal with Syros for blood disorder therapies
Reuters
Mon, 07/24/23 - 09:48 pm
Pfizer
Syros Pharmaceuticals
sickle cell disease
beta thalassemia
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
ICER
gene therapy
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird Bio
drug pricing
sickle cell disease
Bluebird, playing catch-up, gets decision date for sickle cell gene therapy
BioPharma Dive
Wed, 06/21/23 - 11:49 am
Bluebird Bio
gene therapy
sickle cell disease
lovo-cel
FDA
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
gene editing
Editas Medicine
Vertex Pharmaceuticals
CRISPR Therapeutics
EDIT-301
sickle cell disease
beta thalassemia
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia
Bluebird Bio submits BLA for sickle cell disease gene therapy
Biopharma Reporter
Mon, 04/24/23 - 11:39 am
Bluebird Bio
sickle cell disease
lovo-cel
FDA
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
Yahoo/Reuters
Thu, 04/13/23 - 10:01 am
Vertex Pharmaceutials
CRISPR Therapeutics
gene therapy
sickle cell disease
ICER
Could This Move Make Vertex's Next Blockbuster Even Bigger?
Motley Fool
Wed, 04/12/23 - 11:34 am
Vertex Pharmaceuticals
exa-cel
beta thalassemia
sickle cell disease
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Yahoo/Businesswire
Mon, 04/3/23 - 10:09 am
Vertex Pharmaceuticals
CRISPR Therapeutics
sickle cell disease
beta thalassemia
FDA
exa-cel
Bluebird to miss Q1 deadline for lovo-cel filing, shares sliced
Endpoints
Wed, 03/29/23 - 04:04 pm
Bluebird Bio
sickle cell disease
gene therapy
FDA
lovo-cel
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Sun, 02/26/23 - 10:20 pm
Fulcrum Therapeuticsl
FDA
sickle cell disease
clinical trials
FDX-6058
Novartis
Sangamo
Graphite Bio
Novartis Drops SCD Gene Therapy Program with Intellia
BioSpace
Fri, 02/24/23 - 09:03 am
Novartis
sickle cell disease
Intellia Therapeutics
CRISPR
gene editing
Graphite Bio Cuts Sickle Cell Therapy, Half of Staff
BioSpace
Thu, 02/23/23 - 10:19 am
Graphite Bio
sickle cell disease
nula-cel
layoffs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »